YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Central Nervous System Neoplasms
  • Glycoproteins
  • Lectins
  • Lymphoma, Non-Hodgkin
  • Matrix Metalloproteinase 9

abstract

  • In patients with PCNSL, serum levels of YKL-40 and MMP-9 are associated with radiographic disease status. Longitudinal increase in serum levels of YKL-40, but not MMP-9, predicts survival in patients with PCNSL.

publication date

  • July 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/ana.22360

PubMed ID

  • 21391238

Additional Document Info

start page

  • 163

end page

  • 9

volume

  • 70

number

  • 1